IHS Chemical Week

World News and Views :: Top of the News

Merck & Co. Buys Back its Riverside Pharmaceutical Intermediates Plant

1:55 AM MDT | August 11, 2010 | Natasha Alperowicz

Merck & Co. says it will buy back its Riverside, PA pharmaceutical ingedients plant from PRWT Services (Philadelphia), a company that acquired the facility from Merck in 2008. Cherokee Pharmaceuticals, a wholly owned subsidiary of PRWT, is the operator of the plant. The company took over the unit at a time when major drug firms were increasingly outsourcing pharmaceutical ingredients manufacturing to save costs. The plant makes intermediate compounds for two antibiotics, Invanz and Primaxin. It also makes Merck's cholesterol drug, MK524, and Avermectin, an...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa